Project Grant R01DA058636

Award Date 5/1/24
Completion Date 2/28/29
Dollars Obligated $2.2M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Kingston, RI 02881, USA
Similar Awards
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to enhance the understanding and prediction of heavy drinking episodes during the initial recovery from alcohol use disorder (AUD). The $1,373,036 award to Yale University will leverage wearable biosensor technology and advanced artificial intelligence (AI) methodologies to: Develop real-time predictive models using sensor...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $385,000.00 to Loyola University of Chicago's Health Sciences Campus to conduct research on integrated treatment approaches for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD). The key objectives of this 3-year research project are to: 1) assess the effectiveness of integrated treatment regimens, including first-line...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) program, will fund a longitudinal study on social cognition deficits and their impact on recovery outcomes for individuals with Alcohol Use Disorder (AUD). The $351,413 award will support a 5-year research project at the University of Florida to: Assess emotion processing abilities and related cognitive/affective functions in recently abstinent...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative and highly scalable digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders (OUD-AUD). The $390,000 award aims to: 1) identify optimal settings and approaches to engage this population in digital CM through Medicaid claims data analysis;...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) provides $206,021 to the University of New Mexico to develop expertise in mindfulness-based interventions, heart rate variability (HRV), quantitative methods, wearable sensors, and mobile health approaches for improving alcohol use disorder (AUD) treatment. The primary objectives are to conduct a mentored research study using wearable sensors to collect...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and evaluate a brief, digitally-enhanced intervention called IMPROVE to reduce alcohol use among individuals receiving medication for opioid use disorder (MOUD). The $630,000 award will be used to adapt the IMPROVE intervention, which targets anxiety sensitivity and intolerance of uncertainty, and conduct a pilot randomized controlled...
This $1,594,478 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a 5-year prospective, observational study of 300 participants initiating treatment with medications for opioid use disorder (MOUD). The key objectives are to: 1) curate a dataset of craving patterns during MOUD using continuous wearable sensor data; 2) model craving trajectories and examine factors associated with opioid use...
This Project Grant award, with a total funding of $882,816, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to advance patient-centered research on posttraumatic stress disorder (PTSD) and substance use disorder (SUD) using meta-analysis of individual patient data (MIPD) and related methodologies. Specifically, the award will: Conduct new analyses on recovery-focused outcomes to evaluate the...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $545,282 to investigate neural mechanisms associated with cognitive reappraisal and alcohol cue reactivity during early abstinence in individuals with alcohol use disorder (AUD). The project aims to 1) determine how neural mechanisms related to reappraisal and alcohol cue-reactivity change across early abstinence...

INTERPLAY OF AFFECT AND PHYSIOLOGY IN THE REAL-TIME PREDICTION OF RETURN TO USE DURING COMMUNITY REINTEGRATION OF SUBSTANCE USERS - PROJECT SUMMARY/ABSTRACT MORE THAN FOUR MILLION U.S. RESIDENTS SEEK TREATMENT FOR SUBSTANCE USE DISORDER (SUD) EACH YEAR. COMMUNITY REINTEGRATION FOLLOWING RESIDENTIAL SUD TREATMENT IS AN ESPECIALLY VULNERABLE TIME, WITHMOST PEOPLE WHO RETURN TO USE FOLLOWING RESIDENTIAL SUD TREATMENT DOING SO IN THE 30 DAYS IMMEDIATELY FOLLOWING DISCHARGE. D DURING INFORMATION AILY MONITORING METHODS SUCH AS ECOLOGICAL MOMENTARY ASSESSMENT (EMA) CAN IDENTIFY HIGHER RISK PERIODS COMMUNITY REINTEGRATION AS WELL AS CLARIFY TIME-SENSITIVE PROXIMAL PREDICTORS OF RETURN TO USE. THIS CAN HELP TAILOR THE TYPE, AMOUNT, AND TIMING OF INTERVENTIONS TO PREVENT AND/OR DELAY RETURN TO USE. OF SUBSTANCE USE AFTERESCAPE FROM AND AVOIDANCE OF NEGATIVE AFFECT ARE LEADING MOTIVES FOR RE-INITIATION PERIODS OF ABSTINENCE. THESE DATA UNDERSCORE AFFECT DYSREGULATION-A WIDELY REGARDED TRANSDIAGNOSTIC RISK FACTOR-AS A KEY TARGET FOR INTERVENTIONS TO BE DELIVERED DURING COMMUNITY REINTEGRATION OF SUD INPATIENTS. YET, KNOWLEDGE/METHODOLOGICAL/POPULATION GAPS LIMIT OUR UNDERSTANDING OF AFFECT DYSREGULATION IN SUD. (1) VIRTUALLY ALL RESEARCH ON RETURN TO USE DURING COMMUNITY REINTEGRATION HAS USED CROSS-SECTIONAL OR TRADITIONAL LONGITUDINAL DESIGNS. PINPOINTING REAL-TIME PROXIMAL PREDICTORS OF RETURN TO USE IS NECESSARY TO INFORM INTERVENTIONS THAT CAN BE DELIVERED WHEN DYSREGULATION AND USE OF STUDIES IN THIS AREA HAVE EXCLUSIVELY FOCUSED ON DYSREGULATION STEMMING FROM NEGATIVE AFFECT. POSITIVE DYSREGULATION SUD INDIVIDUALS ARE MOST IN NEED OR MAY MOST BENEFIT FROM THEM. (2) OUR UNDERSTANDING OF AFFECT IN RISK FOR RETURN TO USE I S LIMITED. INTENSIVE LONGITUDINA L DATA METHODS (E.G., EMA) CAPTURE WITHIN- BETWEEN-PERSON AFFECT DYNAMICS, WHICH MAY IMPROVE DETECTION OF INDIVIDUALS A GREATEST RISK FOR RETURN TO AS WELL AS PINPOINT RISK STATES TO INTERVENE ON IN MOMENTARY INTERVENTIONS. THEY ALSO ALLOW FOR EXAMINATION POTENTIAL CLINICAL TARGETS FOR MOMENTARY INTERVENTIONS, SUCH AS ENGAGEMENT IN AFFECT REGULATION STRATEGIES. 3) AFFEC MAY ALSO INCREASE RISK FOR RETURN TO USE DURING COMMUNITY REINTEGRATION. (4) INDIVIDUALS IN EARLY RECOVERY EXHIBIT AUTONOMIC DYSFUNCTION; THUS, HRV MAY BE AN IMPORTANT BIO-SIGNAL FOR DETECTING T ( T RISK FOR RETURN TO USE DURING COMMUNITY REINTEGRATION. (5) COMMUNITY REINTEGRATION IS A PERIOD OF UNIQUE/INTENSE STRESS FOR PEOPLE WITH SUD. RESEARCH DURING THIS PERIOD IS SEVERELY LIMITED. STUDIES MUST EXAMINE WHETHER FINDINGS TO INFORM INTERVENTIONS FOR THIS POPULATION WILL BE USEFUL FOR MOST PEOPLE WHO EXPERIENCE COMMUNITY REINTEGRATION. ADDRESSING THESE CRITICAL GAPS, WE PROPOSE INTEGRATION OF SUBJECTIVE DATA FROM EMA WITH PHYSIOLOGY FROM THE EMPATICA EMBRACE2, COLLECTED IN INDIVIDUALS' (N=300) NATURAL SETTINGS DURING THE 30 DAYS AFTER RESIDENTIAL SUD TREATMENT. AIM 1 IDENTIFIES FEATURES OF NEGATIVE AND POSITIVE AFFECT DYNAMICS THAT PREDICT RETURN TO USE OUTCOMES DURING COMMUNITY REINTEGRATION OF SUD INPATIENTS. AIM 2 TESTS THEUTILITY OF PHYSIOLOGY FROM A WEARABLEBIOSENSOR IN DETECTING RETURN TO USE. AIM 3ASSESSES THE EXTENT TO WHICH FEATURES OF AFFECT DYNAMICS AND PHYSIOLOGY PROXIMALLY PREDICT RETURN TO USE ACROSS DIVERSE DEMOGRAPHIC AND CLINICAL GROUPS. FINDINGS WILL INFORM EVIDENCE-BASED TOOLS TO PREVENT/DELAY RETURN TO USE DURING COMMUNITY REINTEGRATION.

Posted 4/22/24, 12:00 AM